Nix Activators
Nix activators comprise a diverse array of chemicals, each uniquely influencing the intricate signaling pathways governing Nix expression and function. AICAR, a potent AMP-activated protein kinase (AMPK) activator, directly engages Nix by enhancing AMPK-dependent pathways, offering a direct avenue for activating Nix-mediated responses. Similarly, Dorsomorphin, a BMP inhibitor, indirectly influences Nix by disrupting BMP-dependent pathways, presenting an indirect yet effective method for activating Nix. The PPAR-δ agonist, GW501516, indirectly modulates Nix by targeting PPAR-δ-dependent pathways, showcasing an alternative means of promoting Nix-mediated responses. On the other hand, Deltarasin, a RAS activator, directly engages Nix by activating RAS-dependent pathways, providing a direct and focused mechanism for Nix activation.
Nicotinamide Riboside, acting as a precursor of NAD+, indirectly impacts Nix by influencing NAD+ metabolism and activating SIRT1, contributing to the modulation of Nix expression. Resveratrol, a SIRT1 activator, indirectly influences Nix by targeting SIRT1-dependent pathways, presenting an alternative means of promoting Nix-mediated responses. A769662, an AMPK activator, directly enhances AMPK-dependent pathways to activate Nix, providing a targeted approach for Nix activation. LGX818, a BRAF activator, directly engages Nix by activating the BRAF-MEK-ERK pathway, offering a precise mechanism for Nix activation. RSL3, a ferroptosis activator, directly impacts Nix by targeting ferroptosis-dependent pathways, showcasing a unique avenue for Nix activation. CGP57380, a LKB1 activator, directly engages Nix by activating LKB1-dependent pathways, offering a focused and direct mechanism for Nix activation. These Nix activators collectively constitute a comprehensive toolkit for researchers seeking to unravel the regulatory networks governing Nix expression and function. The nuanced and diverse mechanisms of action of these chemicals shed light on the intricate signaling pathways converging on Nix, enhancing our understanding of the molecular events orchestrated by Nix in various cellular contexts.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR (5-Aminoimidazole-4-carboxamide ribonucleotide), an AMP-activated protein kinase (AMPK) activator, directly influences Nix by targeting AMPK-dependent pathways. By activating AMPK, AICAR enhances downstream events, including the upregulation of Nix. | ||||||
GW501516 | 317318-70-0 | sc-202642 sc-202642A | 1 mg 5 mg | $82.00 $179.00 | 28 | |
GW501516, a PPAR-δ agonist, indirectly influences Nix by targeting PPAR-δ-dependent pathways. By activating PPAR-δ, GW501516 enhances downstream events, including the upregulation of Nix. The PPAR-δ pathway has been implicated in the control of Nix expression, and GW501516's impact on PPAR-δ signaling provides an indirect mechanism for activating Nix-mediated responses by modulating the intricate network of signaling pathways that converge on Nix expression. | ||||||
Nicotinamide riboside | 1341-23-7 | sc-507345 | 10 mg | $411.00 | ||
Nicotinamide Riboside, a precursor of NAD+, indirectly influences Nix by targeting NAD+ metabolism. By enhancing NAD+ levels, Nicotinamide Riboside activates SIRT1, leading to the modulation of Nix expression. The modulation of NAD+ metabolism by Nicotinamide Riboside provides an indirect mechanism for activating Nix-mediated responses by modulating the intricate network of signaling pathways that converge on Nix expression and function. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol, a SIRT1 activator, indirectly influences Nix by targeting SIRT1-dependent pathways. By activating SIRT1, Resveratrol enhances downstream events, including the upregulation of Nix. The SIRT1 pathway has been implicated in the control of Nix expression, and Resveratrol's impact on SIRT1 signaling provides an indirect mechanism for activating Nix-mediated responses by modulating the intricate network of signaling pathways that converge on Nix expression. | ||||||
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $184.00 $741.00 $1076.00 $3417.00 $5304.00 | 23 | |
A769662, an AMP-activated protein kinase (AMPK) activator, directly influences Nix by targeting AMPK-dependent pathways. By activating AMPK, A769662 enhances downstream events, including the upregulation of Nix. The AMPK pathway has been implicated in the control of Nix expression, and A769662's impact on AMPK signaling provides a direct mechanism for activating Nix-mediated responses by modulating the intricate network of signaling pathways that converge on Nix expression. | ||||||
RSL3 | 1219810-16-8 | sc-507385 | 10 mg | $250.00 | ||
RSL3, a ferroptosis activator, directly influences Nix by targeting ferroptosis-dependent pathways. By inducing ferroptosis, RSL3 enhances downstream events, including the upregulation of Nix. The ferroptosis pathway has been implicated in the control of Nix expression, and RSL3's impact on ferroptosis provides a direct mechanism for activating Nix-mediated responses by modulating the intricate network of signaling pathways that converge on Nix expression. | ||||||
CGP 57380 | 522629-08-9 | sc-202993 | 5 mg | $172.00 | 6 | |
CGP57380, a LKB1 activator, directly influences Nix by activating LKB1-dependent pathways. By activating LKB1, CGP57380 enhances downstream events, including the upregulation of Nix. The LKB1 pathway has been implicated in the control of Nix expression, and CGP57380's impact on LKB1 signaling provides a direct mechanism for activating Nix-mediated responses by modulating the intricate network of signaling pathways that converge on Nix expression. | ||||||